March 26, 2018
GeNeuro Phase 2 aiming HERVs in multiple sclerosis, first time with benefit shown in clinical trial
GeNeuro’s results from the Phase 2b study of its novel therapeutic treatment of multiple sclerosis (MS) showed a significant, consistent positive…